(19)
(11) EP 0 956 352 A1

(12)

(43) Date of publication:
17.11.1999 Bulletin 1999/46

(21) Application number: 97944467.0

(22) Date of filing: 26.09.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 39/ 245( . )
A61P 31/ 22( . )
C12N 15/ 38( . )
A61K 31/ 711( . )
A61K 48/ 00( . )
C07K 14/ 035( . )
(86) International application number:
PCT/US1997/017262
(87) International publication number:
WO 1998/014586 (09.04.1998 Gazette 1998/14)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 01.10.1996 US 19960720758

(71) Applicant: Merck & Co., Inc. (a New Jersey corp.)
Rahway, N.J. 07065 (US)

(72) Inventors:
  • ARMSTRONG, Marcy, E.
    Rahway, NJ 07065 (US)
  • KEYS, Robert, D.
    Birmingham, AL 35222 (US)
  • LEWIS, John, A.
    Rahway, NJ 07065 (US)
  • LIU, Margaret, A.
    Rahway, NJ 07065 (US)
  • McCLEMENTS, William, L.
    Rahway, NJ 07065 (US)

(74) Representative: Thompson, John Dr. 
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) A POLYNUCLEOTIDE HERPES VIRUS VACCINE